10/12/2018Mesoblast and Tasly Complete Strategic Cardiovascular Partnership in C...

10/11/2018NEJM and CCA Enter Partnership for CVS Research and Training

10/11/2018MEI Pharma and BeiGene Announce Collaboration for ME-401/Zanubrutinib ...

10/10/2018SMIA Issues Official Notice on Approval of 17 Anticancer Drugs for BMI...

10/9/2018Daiichi Sankyo Enters Deal with MVP for Distribution of Pain Medicine ...

10/9/2018Listed Chinese Pharma Cos Reports Positive Performance in H1

10/8/2018CDE Solicits Comments on Technical Requirements for Manufacturing Site...

10/8/2018NMPA Issues Rules for Communications Related to Drug R&D and Techn...

10/8/2018Biosimilars and Healthcare Policy: What China Can Learn from the EU an...

10/8/2018Amyris Enters into Extensive Partnership with Yifan Pharma

10/8/2018Why China Is Going All Out to Invent New, Stronger, Cheaper Drugs

10/8/2018SCMP: Betting Big on Biotech

9/28/2018Recent Official and Executive Moves

9/28/2018Novartis Enters Deal with CBMG to Make CAR-T Therapy Kymriah

9/27/2018China’s Health Authorities Issue New Rules on Telemedicine

9/27/2018I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics

9/27/2018Alvotech and Changchun HiTech Agree to Codevelop Biosimilars in China

9/27/2018PharmaBlock Acquires Manufacturing Facility in China

9/27/2018The Development of Antibody-drug Conjugates in China

9/26/2018NMPA Restores Import of Cubist Pharma’s Cubicin after Re-inpsection

9/26/2018Reuters: As China Builds Biotech Sector, Cash Floods U.S. Startups

9/26/2018Flow Pharma Forms Chinese JV for FlowVax Vaccines

9/25/2018China to Begin Clinical Trials of New HPV Vaccine with Help of Gardasi...

9/25/2018Chinese Pharma Market Primed for Growth after Sweeping Reforms

9/25/2018CSPC Pharma and Verastem Oncology Sign Exclusive License for Anticance...

9/25/2018AZ and MSD Publish Retail Price of First PARP inhibitor for Ovarian Ca...

9/21/2018Recent Executive Moves

9/21/2018Impending Tariffs on China to Impact Manufacturers of Dietary Suppleme...

9/20/2018CDE Solicits Comments on Core Considerations for Clinical Protocol Des...

9/20/2018CDE Seeks Comments on Draft Chinese Translations of Seven ICH Guidelin...

Page:158/361 Total number of articles:10807: [First][<<] [156] [157] [158] [159] [160] [>>] [End]